Cite
Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug
MLA
Fidencio Davalos, et al. “Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug.” Translational Oncology, vol. 9, no. 3, June 2016, pp. 248–50. EBSCOhost, https://doi.org/10.1016/j.tranon.2015.12.004.
APA
Fidencio Davalos, Benjamin Chaucer, Wahib Zafar, Shamim Salman, & Jay Nfonoyim. (2016). Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug. Translational Oncology, 9(3), 248–250. https://doi.org/10.1016/j.tranon.2015.12.004
Chicago
Fidencio Davalos, Benjamin Chaucer, Wahib Zafar, Shamim Salman, and Jay Nfonoyim. 2016. “Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug.” Translational Oncology 9 (3): 248–50. doi:10.1016/j.tranon.2015.12.004.